Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-006313·Kezar Life Sciences, Inc.
Schedule 13D ownership disclosure
KEZAR LIFE SCIENCES INC
Common Stock, par value $0.001 per share · CUSIP: 49372L100
Event date: 2024-12-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morningside Venture Investments LimitedReported CIK 0001543112
Shares: 0.0 · Class: 0%
- Frances Anne Elizabeth Richard
Shares: 0.0 · Class: 0%
- Jill Marie Franklin
Shares: 0.0 · Class: 0%
- Peter Stuart Allenby Edwards
Shares: 0.0 · Class: 0%
- Cheung Ka Ho
Shares: 0.0 · Class: 0%
- Equal Talent Investments LimitedReported CIK 0001769229
Shares: 616,502 · Class: 8.45%
- Suk Ying Pauli Ng
Shares: 616,502 · Class: 8.45%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-006313
- Form type
- SCHEDULE 13D/A
- Filer
- Kezar Life Sciences, Inc.
- CIK
- CIK 1645666
- Filed
- Jan 16, 2025
- Reporting period
- Dec 03, 2024
- Description
- Schedule 13D beneficial ownership